The American Psychological Association is holding its annual meeting this week, where the association will unveil a new report that suggests that treating insomnia could be useful for treating people with multiple sclerosis (MS).
The report, entitled “Insomnia Treatment and Multiple Sclerosis: A Meta-Analysis of the Evidence,” looks at the literature on treatment of people with MS, including medications, cognitive behavioral therapy, physical therapy, and cognitive-behavioral therapy.
As the APA’s new report notes, people with chronic pain, including people with fibromyalgia, may benefit from cognitive-behavioral therapy, which may help improve quality of life, according to the APAs new findings.
But, the report warns, this treatment might not be helpful for people with other conditions, such as anxiety disorders, which are a significant public health problem in the United States.
“There are several reasons why these treatments don’t appear to be as effective as we hope,” APA chair, Katherine D’Agostino, told reporters during the APAC conference.
The APA says that its findings may help inform research that could lead to better treatments.
The APA did not provide any details about how the group determined that cognitive behavioral treatment is effective.
The new report also includes a summary of some research from the last 15 years that looked at the efficacy of cognitive behavioral treatments in people with autism spectrum disorder (ASD), autism spectrum disorders (ASDs), and bipolar disorder.
The report found that cognitive-Behavioral Therapy, Cognitive Behavioral Therapy (CBT), and Cognitive Therapy (CT) may have a significant effect on autism symptoms and quality of daily living.
However, the APAPA notes that there are currently no randomized controlled trials that have shown that CBT or CT have a beneficial effect on MS, although studies have found some positive results.
“This means there is no definitive evidence that CBTT is effective for MS,” D’Abostino said.
D’Agostaino said that researchers have long believed that people with different forms of MS are different in how they experience sleep problems.
“The more they have to sleep, the more their quality of sleep is affected, and that is because they have different brain cells that are not functioning the same,” Dabostino explained.
“If you want to improve the quality of their sleep, you want them to have different cells that work.”
The APAPAs new report does not address whether or not people with specific types of MS experience sleep abnormalities in the absence of a sleep disorder, but it does note that there may be ways to help people with these conditions who don’t have MS.
For instance, the study suggests that cognitive therapies may be effective for people who have other sleep problems, such an irritable bowel syndrome (IBS), but these therapies may not be as helpful for those who do have IBS, such a celiac disease.
“People with celiac, as well as people with irritable Bowel Syndrome, have different patterns of sleep, which means they need different types of cognitive therapies,” Dabsio said.
“These types of therapies may provide benefits for people that do have a sleep disturbance.”
According to the researchers, there are some limitations to the research that they did in the new report.
For instance, there is little evidence that a particular type of cognitive therapy is better for MS than a different type of therapy, such therapy could be different for different people, or it could be that a different cognitive therapy might be effective in some people and not in others.
“We don’t know that this is the case,” Dabbos said.
But the researchers noted that the study included a large number of people, so the results are valid for a broad group of people.
Another limitation is that people are typically less likely to take part in the research if they have a serious medical condition that might interfere with their ability to participate.
“You can’t tell if someone is having MS or not,” Dabanos said, adding that there is a possibility that some people with an underlying medical condition might have a higher chance of getting sick.
For people with a chronic condition, the risk of being excluded from the study may be higher.